Skip to content

Clinical trials

Phase 2 Multiple Myeloma trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Phase: Phase 2 Country / region: Netherlands Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20082
20101
20111
20121
20142
20151
20162
20172
20181
20194
20213
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting4
Active, not recruiting3
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC7
Celgene2
European Myeloma Network B.V.2
Novartis Pharmaceuticals2
Radboud University Medical Center2
Stichting European Myeloma Network2
Amsterdam UMC, location VUmc1
Bristol-Myers Squibb1
Centocor, Inc.1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma26
Recurrence3
Febrile Neutropenia2
Mucositis2
Biliary Tract Neoplasms1
Gastrointestinal Stromal Tumors1
Glioma1
Hematologic Neoplasms1
Leukemia, Hairy Cell1
Lymphoma1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.